Could some breast cancer patients skip surgery? new trial investigates
NCT ID NCT07357948
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether women with triple-negative breast cancer who have a complete response to chemo-immunotherapy can safely skip breast and lymph node surgery. Half of the 150 participants will receive standard care including surgery, while the other half will have no surgery. The goal is to see if avoiding surgery leads to similar cancer control with fewer side effects and better quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
omission of surgery
What this could lead to
If successful, this could allow some women with triple-negative breast cancer to avoid surgery after chemo-immunotherapy, reducing complications and improving quality of life while maintaining cancer control.
What could go wrong
This is a phase 2 trial with only 150 participants, so results are preliminary. Skipping surgery might increase the risk of cancer returning in the breast or lymph nodes, and the approach may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Georges-François Leclerc
Dijon, 21000, France
Contact
Contact
-
Hôpital Tenon
Paris, 75020, France
Contact
Contact
-
Institut Curie Saint-Cloud
Saint-Cloud, 92210, France
Contact
Contact
-
Institut Curie-Paris
Paris, 75005, France
Contact
Contact